Accordingly, this study evaluated the PPARα/δ-activated SIRT1-mediated molecular mechanism and effects of chronic elafibranor treatment on the progression of CKD in HFD-fed obese mice with steatohepatitis. The gene discussed is SIRT1; the disease is chronic kidney disease.